Cargando…
Network pharmacology of triptolide in cancer cells: implications for transcription factor binding
Background Triptolide is an active natural product, which inhibits cell proliferation, induces cell apoptosis, suppresses tumor metastasis and improves the effect of other therapeutic treatments in several cancer cell lines by affecting multiple molecules and signaling pathways, such as caspases, he...
Autores principales: | Seo, Ean-Jeong, Dawood, Mona, Hult, Annika K., Olsson, Martin L., Efferth, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541937/ https://www.ncbi.nlm.nih.gov/pubmed/34213719 http://dx.doi.org/10.1007/s10637-021-01137-y |
Ejemplares similares
-
A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy
por: Fischer, Nicolas, et al.
Publicado: (2021) -
Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myeloma
por: Özenver, Nadire, et al.
Publicado: (2020) -
The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4
por: Chen, Wenhu, et al.
Publicado: (2023) -
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
por: Saeed, Mohamed E. M., et al.
Publicado: (2020) -
Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics
por: Lewis Phillips, Gail, et al.
Publicado: (2021)